Back

Effects of blood pressure lowering drugs in heart failure: a systematic review and meta-analysis of randomised controlled trials

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Hypertension: epidemiology, targets and comorbidities Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Ana Catarina Pinho-Gomes

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
2018 ESC/ESH guideline-recommended age categories and intensive blood pressure management in high-risk adults: insights from SPRINT
Doctor M. Pareek (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
All-cause mortality and cardiovascular death according to blood pressure thresholds recommended by ACC/AHA
Doctor G. Joseph (Roskilde, DK)
Abstract Slides
Presentation thumbnail
Association of systolic blood pressure and cardiovascular outcomes at different age groups in the healthy general population: a nationwide prospective cohort study
Doctor M. Jung (Seoul, KR)
Abstract Slides
Presentation thumbnail
Restricted mean survival time analysis to assess efficacy and safety of intensive vs standard blood pressure treatment goals as a function of age: insights from the SPRINT trial
Doctor A. Krishnaswami (San Jose, US)
Abstract Slides
Presentation thumbnail
Do hypertensive women with coronary artery disease benefit from lowering systolic blood pressure under 130 mmHg? Long-term mortality in the INternational VErapamil SR-trandolapril STudy (INVEST)
Doctor R. Sava (Tournai, BE)
Abstract Slides

Access the full session

Session thumbnail
Hypertension: epidemiology, targets and comorbidities

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
The floor is yours: bring your questions about optimal blood pressure control for organ protection - expert panel
thumbnail
Congress Presentation
Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?
thumbnail
Congress Presentation
Hypertension and glucose

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources